Occudo Quantitative Strategies Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eaton
ETN
|
+$18.8M |
| 2 |
Spotify
SPOT
|
+$16.2M |
| 3 |
Palantir
PLTR
|
+$15.1M |
| 4 |
Trane Technologies
TT
|
+$14.4M |
| 5 |
Cintas
CTAS
|
+$14.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intuitive Surgical
ISRG
|
+$10.2M |
| 2 |
Lam Research
LRCX
|
+$9.45M |
| 3 |
Progressive
PGR
|
+$9M |
| 4 |
Salesforce
CRM
|
+$8.94M |
| 5 |
Dover
DOV
|
+$8.44M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.36% |
| 2 | Industrials | 19.83% |
| 3 | Consumer Discretionary | 13.57% |
| 4 | Financials | 8.96% |
| 5 | Healthcare | 7.88% |
Similar funds
Occudo Quantitative Strategies's Q4 2025 Portfolio in Review
As of Q4 2025, Occudo Quantitative Strategies held 941 positions worth $1.49B, up 82% from $821M the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Occudo Quantitative Strategies deployed $678M of net new capital in Q4 2025, opening 298 new positions and adding to 244 existing holdings. Its largest new stake was Eaton: 52,983 shares worth $16.9M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Industrials and Consumer Discretionary.
On the sell side, the largest reduction was Intuitive Surgical, an estimated $10.2M trimmed.
- Occudo Quantitative Strategies's largest Q4 2025 buy was Eaton: 52,983 shares worth $16.9M.
- Occudo Quantitative Strategies added most to Palantir in Q4 2025, an estimated $15.1M increase.
- Occudo Quantitative Strategies's biggest Q4 2025 reduction was Intuitive Surgical, cutting an estimated $10.2M.
- Occudo Quantitative Strategies fully exited Lam Research in Q4 2025, selling an estimated $9.45M.
- Occudo Quantitative Strategies's ten largest holdings make up 11% of its $1.49B portfolio in Q4 2025.
- Occudo Quantitative Strategies opened 298 new positions and closed 271 in Q4 2025.
- Occudo Quantitative Strategies's portfolio value rose 82% quarter-over-quarter to $1.49B.
Based on Occudo Quantitative Strategies's 13F filing for Q4 2025, filed 17 Feb 2026.